top of page

We have taken PCR to a whole new level. Our Hyperplex PCR™ technology enables detection of up to 100 markers in a single well with highly specific and ultra-sensitive performance.

dots-lightgrey-RGB.png

Today, analysis has limitations

dots-darkgrey-RGB.png

We bring you the future

Efficiency & Performance

To overcome these challenges, there is a need for new, accurate molecular testing solutions that can detect multiple, difficult and low abundance markers while simultaneously handle large sample volumes and seamlessly integrate into existing lab workflows without the need for substantial equipment investment.

Efficiency

PCR has long been the go-to molecular testing method providing scalability and highly sensitive results. However, it may become impractical or costly for high-throughput projects where broad genomic insight is required, or when there is a need to detect difficult, numerous target sequences in a single sample.

Or

Performance

In comparison, NGS approaches excel in discovering novel genes and provide extreme sequence specificity. Yet, the initial equipment costs, ongoing reagent expenses, service fees, training required and turnaround time to results present significant barriers for many labs.​

dots-gradient-RGB.png
Introducing

An end-point quantitative PCR technology powered by Nanopixels™, padlock probes and RCA-based molecular counting ensuring single-nucleotide resolution and ultra-sensitivity together with hyperplex capabilities to detect 100+ targets in each well.

Analysis without compromise

Wider view

Detect up to 100 targets in a single sample


Deeper understanding

Highly specific and ultra-sensitive


Faster answers

Results within 4 hours


Seamless integration

Works with standard equipment and consumables

Powered by Nanopixels™ and Padlock-probes
Analysis without compromise
How we compare to other technologies

Deeper, Wider, Faster

Challenges
We Are Solving

Latest from
APLEX Bio

Meet Aplex Bio at CES2024

11 dec. 2023

Aplex Bio selected as Deep Tech Pioneer by Hello Tomorrow

5 dec. 2023

Aplex Bio receives SEK 240,000 funding from Vinnova

2 nov. 2023

Supported by

Partner_Scilife_white.png
Partner_EIT_white.png
Partner_KIAB_white.png
Partner_Vinnova
bottom of page